rs2673169

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004525.3(LRP2):​c.311-786C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.312 in 151,756 control chromosomes in the GnomAD database, including 8,225 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.31 ( 8225 hom., cov: 32)

Consequence

LRP2
NM_004525.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.371

Publications

2 publications found
Variant links:
Genes affected
LRP2 (HGNC:6694): (LDL receptor related protein 2) The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycoprotein has a large amino-terminal extracellular domain, a single transmembrane domain, and a short carboxy-terminal cytoplasmic tail. The extracellular ligand-binding-domains bind diverse macromolecules including albumin, apolipoproteins B and E, and lipoprotein lipase. The LRP2 protein is critical for the reuptake of numerous ligands, including lipoproteins, sterols, vitamin-binding proteins, and hormones. This protein also has a role in cell-signaling; extracellular ligands include parathyroid horomones and the morphogen sonic hedgehog while cytosolic ligands include MAP kinase scaffold proteins and JNK interacting proteins. Recycling of this membrane receptor is regulated by phosphorylation of its cytoplasmic domain. Mutations in this gene cause Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).[provided by RefSeq, Aug 2009]
LRP2 Gene-Disease associations (from GenCC):
  • Donnai-Barrow syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • Stickler syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • congenital heart disease
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.467 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004525.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRP2
NM_004525.3
MANE Select
c.311-786C>G
intron
N/ANP_004516.2P98164

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LRP2
ENST00000649046.1
MANE Select
c.311-786C>G
intron
N/AENSP00000496870.1P98164
LRP2
ENST00000443831.1
TSL:2
c.311-786C>G
intron
N/AENSP00000409813.1E9PC35

Frequencies

GnomAD3 genomes
AF:
0.312
AC:
47347
AN:
151640
Hom.:
8204
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.472
Gnomad AMI
AF:
0.228
Gnomad AMR
AF:
0.225
Gnomad ASJ
AF:
0.305
Gnomad EAS
AF:
0.0737
Gnomad SAS
AF:
0.169
Gnomad FIN
AF:
0.250
Gnomad MID
AF:
0.275
Gnomad NFE
AF:
0.275
Gnomad OTH
AF:
0.296
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.312
AC:
47408
AN:
151756
Hom.:
8225
Cov.:
32
AF XY:
0.309
AC XY:
22944
AN XY:
74170
show subpopulations
African (AFR)
AF:
0.473
AC:
19552
AN:
41346
American (AMR)
AF:
0.224
AC:
3419
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.305
AC:
1057
AN:
3470
East Asian (EAS)
AF:
0.0739
AC:
382
AN:
5170
South Asian (SAS)
AF:
0.169
AC:
814
AN:
4806
European-Finnish (FIN)
AF:
0.250
AC:
2626
AN:
10510
Middle Eastern (MID)
AF:
0.267
AC:
78
AN:
292
European-Non Finnish (NFE)
AF:
0.275
AC:
18658
AN:
67906
Other (OTH)
AF:
0.293
AC:
614
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1566
3131
4697
6262
7828
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
460
920
1380
1840
2300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.303
Hom.:
945
Bravo
AF:
0.317
Asia WGS
AF:
0.147
AC:
512
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.82
DANN
Benign
0.40
PhyloP100
-0.37
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2673169; hg19: chr2-170164693; API